GINA LIEBL: Open Payments
NPI 1588224059 · GREAT BEND, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 50 payments from 13 companies in 2025. Trend: 2023 $1,631 · 2024 $1,205 · 2025 $896
Food & beverage: $697Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $231 |
| ABBVIE INC. | 13 | $178 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Amgen Inc. | 5 | $78 |
| E.R. Squibb & Sons, L.L.C. | 3 | $68 |
| UCB, Inc. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| Galderma Laboratories, L.P. | 2 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $31 |
| Integra LifeSciences Corporation | 1 | $23 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, OTEZLA, RINVOQ, Sotyktu, Bimzelx, COSENTYX.
Industry payments across KS — which companies pay providers there.
